Pier 88 Investment Partners LLC Heron Therapeutics, Inc. Transaction History

Pier 88 Investment Partners LLC

$87 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$2.25 - $4.67 $72,675 - $150,841	32,300 Added 116.61%	60,000 $150,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $71,820 - $144,990	27,000 Added 3857.14%	27,700 $117,000
Q2 2022 Aug 12, 2022	SELL	$2.3 - $6.29 $311,949 - $853,112	-135,630 Reduced 99.49%	700 $2,000
Q1 2022 May 13, 2022	BUY	$4.63 - $9.94 $173,625 - $372,750	37,500 Added 37.94%	136,330 $780,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $433,365 - $653,940	51,900 Added 110.59%	98,830 $902,000
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $33,631 - $49,800	3,320 Added 7.61%	46,930 $502,000
Q1 2021 May 14, 2021	SELL	$14.49 - $20.72 $69,552 - $99,456	-4,800 Reduced 9.92%	43,610 $707,000
Q4 2020 Feb 12, 2021	BUY	$14.61 - $22.14 $156,765 - $237,562	10,730 Added 28.48%	48,410 $1.94 Million
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $275,395 - $357,994	-20,146 Reduced 34.84%	37,680 $558,000
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $134,556 - $265,283	12,356 Added 27.17%	57,826 $850,000
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $169,818 - $407,696	16,600 Added 57.5%	45,470 $534,000
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $287,430 - $439,065	-16,500 Reduced 36.37%	28,870 $678,000
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $176,442 - $230,691	10,785 Added 31.18%	45,370 $839,000
Q2 2019 Aug 08, 2019	SELL	$16.93 - $26.22 $13,374 - $20,713	-790 Reduced 2.23%	34,585 $643,000
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $321,090 - $393,075	13,870 Added 64.5%	35,375 $865,000
Q4 2018 Feb 11, 2019	BUY	$22.03 - $32.01 $96,932 - $140,844	4,400 Added 25.72%	21,505 $558,000
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $164,700 - $224,266	5,490 Added 47.27%	17,105 $541,000
Q2 2018 Jul 25, 2018	BUY	$26.4 - $42.0 $306,636 - $487,830	11,615 New	11,615 $451,000

Others Institutions Holding HRTX

# of Institutions

193

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

Rubric Capital Management LP New York, NY

26.7M
Shares

$51 Million
2.77% of portfolio
Vanguard Group Inc Valley Forge, PA

8.62M
Shares

$16.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$15.9 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

7.6M
Shares

$14.5 Million
0.05% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$13.3 Million
58.47% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.

Account